Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutral technetium(II)-99m complexes as potential brain perfusion imaging agents.

M Neves1, K Libson, E Deutsch

  • 1Department of Chemistry, University of Cincinnati, OH 45221.

International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|January 1, 1987
PubMed
Summary

New technetium-99m complexes show promise as brain imaging agents. Researchers found that neutral technetium(II) complexes, and surprisingly, cationic technetium(III) analogs, exhibit significant brain uptake in rats.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Implementation of the global risk analysis in pulsed-dose rate brachytherapy: methods and results.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2015
Same author

Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.

Cell death & disease·2014
Same author

[Stereotactic body radiation therapy in the management of liver tumours].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2014
Same author

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.

The British journal of radiology·2014

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Pharmacology

Background:

  • Technetium-99m (99mTc) is a crucial radioisotope for medical imaging.
  • Developing targeted 99mTc-based radiopharmaceuticals is essential for diagnostic advancements.

Purpose of the Study:

  • To synthesize and characterize novel neutral technetium(II) complexes.
  • To evaluate the brain uptake of these complexes and their cationic technetium(III) analogs in vivo.
  • To explore their potential as brain perfusion imaging agents.

Main Methods:

  • Preparation and characterization of eight neutral technetium(II) complexes (tr-[99mTcIID2X2]0).
  • High-performance liquid chromatography (HPLC) for comparison with known technetium-99 analogs.
  • In vivo brain uptake studies in rats following intravenous injection.

Related Experiment Videos

Main Results:

  • Several neutral technetium(II) complexes demonstrated significant brain uptake.
  • The complex tr-[99mTcII(DIARS)2Cl2]0 showed maximum uptake (1.2% dose/brain at 1 min).
  • Cationic technetium(III) analogs also exhibited brain uptake, suggesting in vivo reduction to Tc(II).

Conclusions:

  • The chemical and biological properties of technetium(II) and technetium(III) complexes are interrelated.
  • These technetium complexes offer potential for developing effective 99mTc brain perfusion imaging agents.
  • Further manipulation of ligand structures (D and X) could optimize imaging characteristics.